CN101274051A - Compound formulation of capsules for curing barrenness and preparing technique - Google Patents

Compound formulation of capsules for curing barrenness and preparing technique Download PDF

Info

Publication number
CN101274051A
CN101274051A CNA2007100541159A CN200710054115A CN101274051A CN 101274051 A CN101274051 A CN 101274051A CN A2007100541159 A CNA2007100541159 A CN A2007100541159A CN 200710054115 A CN200710054115 A CN 200710054115A CN 101274051 A CN101274051 A CN 101274051A
Authority
CN
China
Prior art keywords
percent
capsule
infertility
radix
compound formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007100541159A
Other languages
Chinese (zh)
Inventor
武小力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HAISIKE (HENAN) BIOLOGICAL SCI-TECH Co Ltd
Original Assignee
HAISIKE (HENAN) BIOLOGICAL SCI-TECH Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HAISIKE (HENAN) BIOLOGICAL SCI-TECH Co Ltd filed Critical HAISIKE (HENAN) BIOLOGICAL SCI-TECH Co Ltd
Priority to CNA2007100541159A priority Critical patent/CN101274051A/en
Publication of CN101274051A publication Critical patent/CN101274051A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention relates to a method for combining a capsule applied to treating infertility and a preparation method thereof. 5 to 7 percent of Chinese angelic, 6 to 8 percent of white paeony root, 1 to 3 percent of chuanxiong rhizoma, 1 to 3 percent of safflower, 3 to 5 percent of semen persicae, 3 to 5 percent of herba lycopi, 40 to 60 percent of barbary wolfberry fruit, 3 to 5 percent of scaly anteater, 7 to 9 percent of rehmannia root and 3 to 5 percent of rhizoma cyperi are taken as raw materials, mixed, dried, ground, put into capsules, irradiated, checked and then the finished products are formed and put into storages. The capsule can effectively treat symptoms of infirmity, frequent dizziness and infertility and can recuperate symptoms of infirmity, frequent dizziness, infertility and all parts of body to a normal status after a long period of capsule usage; besides, human body has no dependence on pure Chinese herbal product and the price of the capsule is low, therefore, the capsule is especially suitable for mass consumption and being operated by manufacturers.

Description

Capsular compound formulation of a kind of treatment infertility and processing technology
Affiliated technical field:
The present invention relates to the processing technology of compound formulation of capsules, capsular compound formulation of especially a kind of treatment infertility and processing technology.
Background technology:
At present, along with growth in the living standard, people more pay attention to drinking and eating from the diet aspect, healthy green health and tonic, health care has also entered the common people's life thereupon, and is as physical weakness, often dizzy, infertility occurs and allow the people neglect especially, go out China's application (patent) number by retrieval: 02139328.1 applying date: 2002.08.03 open (bulletin) number: CN1401382 open (bulletin) day: 2003.03.12
Application (patent) number: 01133502.5 applying date: 2001.09.26 open (bulletin) number: CN1410081 open (bulletin) day: 2003.04.16
Summary of the invention:
The present invention is in order to solve physical weakness, often dizzy, a difficult problem that infertility occurs provides a kind of assembly than (weight) and processing technology: Radix Angelicae Sinensis 5-7% Radix Paeoniae Alba 6-8% Rhizoma Chuanxiong 1-3% Flos Carthami 1-3% Semen Persicae 3-5% Herba Lycopi 3-5% Fructus Lycii 40-60% Squama Manis 3-5% Radix Rehmanniae 7-9% Rhizoma Cyperi 3-5%.Get above raw material mixing and dry, pulverize, incapsulate, be the finished product warehouse-in after irradiation, the check.
Best group proportioning (weight) is: Radix Angelicae Sinensis 6% Radix Paeoniae Alba 7% Rhizoma Chuanxiong 3% Flos Carthami 2% Semen Persicae 4% Herba Lycopi 4% Fructus Lycii 50% Squama Manis 4% Radix Rehmanniae 8% Rhizoma Cyperi 4%, and get above raw material mixing and dry, pulverize, incapsulate, be the finished product warehouse-in after irradiation, the check.
Beneficial effect:
The invention has the beneficial effects as follows: can effectively be physical weakness, often dizzy, the infertility symptom occurring obtains medical treatment, taking for a long time can be with physical weakness, and often dizziness the infertility symptom occurs and nurses one's health to normal condition, can feel that parts of body returns back to normal condition, and pure Chinese medicine product is to the human body no dependence, and price is the end again, is particularly suitable for the operation of mass consumption and manufacturer.
Description of drawings:
The present invention is further described below in conjunction with accompanying drawing:
Fig. 1 is a process chart of the present invention.
Embodiment one:
Radix Angelicae Sinensis 5-7% Radix Paeoniae Alba 6-8% Rhizoma Chuanxiong 1-3% Flos Carthami 1-3% Semen Persicae 3-5% Herba Lycopi 3-5% Fructus Lycii 40-60% Squama Manis 3-5% Radix Rehmanniae 7-9% Rhizoma Cyperi 3-5%.Get above raw material mixing and dry, pulverize, incapsulate, be the finished product warehouse-in after irradiation, the check.
Embodiment two:
Radix Angelicae Sinensis 5% Radix Paeoniae Alba 6% Rhizoma Chuanxiong 1% Flos Carthami 1% Semen Persicae 3% Herba Lycopi 3% Fructus Lycii 40% Squama Manis 3% Radix Rehmanniae 7% Rhizoma Cyperi 3%
Embodiment three:
Radix Angelicae Sinensis 7% Radix Paeoniae Alba 8% Rhizoma Chuanxiong 3% Flos Carthami 3% Semen Persicae 5% Herba Lycopi 5% Fructus Lycii 60% Squama Manis 5% Radix Rehmanniae 9% Rhizoma Cyperi 5%.
The specific embodiment:
Radix Angelicae Sinensis 6% Radix Paeoniae Alba 7% Rhizoma Chuanxiong 3% Flos Carthami 2% Semen Persicae 4% Herba Lycopi 4% Fructus Lycii 50% Squama Manis 4% Radix Rehmanniae 8% Rhizoma Cyperi 4% is got above raw material mixing and dries, pulverizes, incapsulates, and is the finished product warehouse-in after irradiation, the check.

Claims (3)

1. treat capsular compound formulation of infertility and processing technology for one kind, it is characterized in that: Radix Angelicae Sinensis 5-7% Radix Paeoniae Alba 6-8% Rhizoma Chuanxiong 1-3% Flos Carthami 1-3% Semen Persicae 3-5% Herba Lycopi 3-5% Fructus Lycii 40-60% Squama Manis 3-5% Radix Rehmanniae 7-9% Rhizoma Cyperi 3-5%, get above raw material mixing and dry, pulverize, incapsulate, be the finished product warehouse-in after irradiation, the check.
2. according to capsular compound formulation of a kind of treatment infertility and the processing technology described in the claim 1, it is characterized in that: Radix Angelicae Sinensis 5% Radix Paeoniae Alba 6% Rhizoma Chuanxiong 1% Flos Carthami 1% Semen Persicae 3% Herba Lycopi 3% Fructus Lycii 40% Squama Manis 3% Radix Rehmanniae 7% Rhizoma Cyperi 3%.
3. according to capsular compound formulation of a kind of treatment infertility and the processing technology described in the claim 1, it is characterized in that: Radix Angelicae Sinensis 7% Radix Paeoniae Alba 8% Rhizoma Chuanxiong 3% Flos Carthami 3% Semen Persicae 5% Herba Lycopi 5% Fructus Lycii 60% Squama Manis 5% Radix Rehmanniae 9% Rhizoma Cyperi 5%, get above raw material mixing and dry, pulverize, incapsulate, be the finished product warehouse-in after irradiation, the check.
CNA2007100541159A 2007-03-27 2007-03-27 Compound formulation of capsules for curing barrenness and preparing technique Pending CN101274051A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007100541159A CN101274051A (en) 2007-03-27 2007-03-27 Compound formulation of capsules for curing barrenness and preparing technique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007100541159A CN101274051A (en) 2007-03-27 2007-03-27 Compound formulation of capsules for curing barrenness and preparing technique

Publications (1)

Publication Number Publication Date
CN101274051A true CN101274051A (en) 2008-10-01

Family

ID=39994187

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007100541159A Pending CN101274051A (en) 2007-03-27 2007-03-27 Compound formulation of capsules for curing barrenness and preparing technique

Country Status (1)

Country Link
CN (1) CN101274051A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102949664A (en) * 2012-11-13 2013-03-06 刘晓燕 Traditional Chinese medicinal composite for treating fallopian-tube obstructive infertility
CN103263557A (en) * 2013-06-01 2013-08-28 陈静静 Traditional Chinese medicine formula for treating infertility
CN103494988A (en) * 2012-03-29 2014-01-08 海丝克(河南)生物科技有限公司 Formulation method of formula for treating infertility
CN103638252A (en) * 2013-11-29 2014-03-19 张保金 Traditional Chinese medicine for treating infertility of women

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103494988A (en) * 2012-03-29 2014-01-08 海丝克(河南)生物科技有限公司 Formulation method of formula for treating infertility
CN103494988B (en) * 2012-03-29 2015-11-25 海丝克(河南)生物科技有限公司 A kind of Chinese medicine composition for the treatment of infertility
CN102949664A (en) * 2012-11-13 2013-03-06 刘晓燕 Traditional Chinese medicinal composite for treating fallopian-tube obstructive infertility
CN103263557A (en) * 2013-06-01 2013-08-28 陈静静 Traditional Chinese medicine formula for treating infertility
CN103638252A (en) * 2013-11-29 2014-03-19 张保金 Traditional Chinese medicine for treating infertility of women

Similar Documents

Publication Publication Date Title
CN101391058B (en) Preparation for clearing away the heat-evil and expelling superficial evils
CN100496586C (en) Medicinal liquor for treating hyperosteogency and koilorrhachic
CN102000174A (en) Traditional Chinese medicine oral administration formula for whitening
CN101274009A (en) Compound formulation of capsules for curing lumbocrural pain and preparing technique
CN101569737A (en) Medicine for gynecoiatry and health care and preparation method thereof
CN101274051A (en) Compound formulation of capsules for curing barrenness and preparing technique
CN101623446A (en) Chinese medicinal composition for treating alopecia and premature graying of hair
CN101732631B (en) Traditional Chinese medicine composite mask for dispelling acnes
CN103656130A (en) Traditional Chinese medicine composition for treating constipation
CN102048930A (en) Formula of traditional Chinese medicine for treating chronic gastritis
CN101274018A (en) Compound formulation of capsules for curing alopecia and preparing process
CN1063066C (en) Chinese medicine for treatment of gout
CN102370767A (en) Traditional Chinese medicine formula used for treating intestinal obstruction
CN101850071A (en) Chinese medicament for treating chronic nephritis
CN101732622A (en) Chinese medicament for treating ischidrosis
CN101757318A (en) Dehumidifying pill
CN1406617A (en) Tablets against allergic purpura
CN102671042A (en) Traditional Chinese medicinal composition for treating acne and preparation method thereof
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN101554412B (en) Traditional Chinese medicine for treating atrial fibrillation
CN100402068C (en) Hog cholera treating medicine
CN100534485C (en) Preparation prepared by biological chitin and traditional Chinese medicine for postponing senescence
CN101744963A (en) Traditional Chinese medicine preparation for detumescence by detoxification
CN101099818A (en) Traditional Chinese medicine formula for treating leucoderma
CN101274058A (en) Compound formulation of capsules for curing pulmonary tuberculosis with qi-blood deficiency syndrome and preparing technique

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20081001